X

XWELL, Inc. (XWEL)

NCM – Real vaqt narxi. Valyuta: USD

1.39

+0.05 (3.73%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

X

XWELL, Inc. (XWEL)

NCM – Real vaqt narxi. Valyuta: USD

1.39

+0.05 (3.73%)

Yopilishda: May 12, 2026, 4:00 PM EDT

01.04.2026

XWELL Reports Fiscal 2025 Results

NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced financial results for the year ended December 31, 2025.

25.02.2026

XWELL Stock Surges Over 200% After $31.3 Million Private Placement

XWELL Inc (NASDAQ: XWEL) shares are surging on Wednesday following the company's announcement of a private placement expected to generate significant proceeds.

24.02.2026

XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 66,666,669 shares of common stock of the Company at an initial conversion price of $0.47 per share, and (ii) accompanying warrants to purchase up to 66,666,669 shares of the Company's common stock.

03.02.2026

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (Nasdaq: XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance (TGS) program — part of the Biothreat Radar Detection System — which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity.

08.01.2026

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally

18.12.2025

XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station

NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- XWELL (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, is excited to announce the opening of its newest location inside New York City's Pennsylvania Station—a major step in expanding the brand beyond airport terminals and into high-traffic city spaces. “Our entry into Penn Station marks a natural next step for XWELL as we continue evolving to meet people where they are,” said Ezra Ernst, CEO of XWELL.

14.11.2025

XWELL Reports Third Quarter 2025 Results

NEW YORK, Nov. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the third quarter ended September 30, 2025.

Videolar

No Data

There is no data to display

Press-relizlar

01.04.2026

XWELL Reports Fiscal 2025 Results

NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced financial results for the year ended December 31, 2025.

24.02.2026

XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a provider of wellness and biosecurity solutions, today announced that it has entered into a securities purchase agreement with a series of American Ventures, LLC in a private placement that is expected to result in gross proceeds to the Company of approximately $31.3 million, before deducting placement agent fees and offering expenses. The private placement consists of the sale of, (i) approximately 31,333 shares of Series H Convertible Preferred Stock, with a stated value of $1,000 per share, convertible into an aggregate of 66,666,669 shares of common stock of the Company at an initial conversion price of $0.47 per share, and (ii) accompanying warrants to purchase up to 66,666,669 shares of the Company's common stock.

03.02.2026

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- XWELL Inc. (Nasdaq: XWEL), a provider of wellness and biosecurity solutions, today announced a strategic partnership with AI and predictive intelligence company PieQ to develop a next-generation U.S. biosecurity forecasting platform in support of the Centers for Disease Control and Prevention (CDC). The announcement follows a recent CDC milestone for the Traveler-based Genomic Surveillance (TGS) program — part of the Biothreat Radar Detection System — which has surpassed one million voluntary participants with XWELL and Ginkgo Biosecurity.

08.01.2026

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally Company Builds on U.S Biosecurity Leadership to Advance Pathogen Surveillance Internationally

Search stocks

XWELL, Inc. (XWEL)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

XWELL, Inc. (XWEL)

XWELL Reports Fiscal 2025 Results

XWELL Stock Surges Over 200% After $31.3 Million Private Placement

XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor

XWELL Expands Beyond Airports with New Wellness Retail Location in New York City's Pennsylvania Station

XWELL Reports Third Quarter 2025 Results

Videolar

No Data

Press-relizlar

XWELL Reports Fiscal 2025 Results

XWELL Announces Approximately $31.3 Million Private Placement Priced At The Market Under Nasdaq Rules

XWELL and PieQ Advance AI-Powered Biosecurity Forecasting Following CDC Milestone

XWELL Reaffirms Commitment to Biosecurity, Appoints Former CDC Senior Advisor